Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)
Sponsor: Rabin Medical Center
A PHASE1 clinical study on Periodic Fever, this trial is ongoing. The trial is conducted by Rabin Medical Center and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Oct 2018 — Sep 2020 [monthly]
Recruiting PHASE1
Status: Unknown Status → Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Unknown Status PHASE1
-
May 2018 — Jun 2018 [monthly]
Unknown Status PHASE1
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — May 2018 [monthly]
Not Yet Recruiting PHASE1
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rabin Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .